Timing is everything! If you are passionate about Freenome's mission and want to contribute in a meaningful way, we encourage you to submit your CV or resume.
About Freenome
Freenome is on a mission to empower everyone with the tools they need to detect, treat, and ultimately prevent diseases.
By applying advanced machine learning techniques to recent breakthroughs in genomic science, Freenome is developing simple blood tests to detect early-stage cancer and make treatments more effective. The company has raised $238 million from investors such as RA Capital, Polaris Partners, Perceptive Advisors, Andreessen Horowitz, funds and accounts advised by T. Rowe Price Associates, Inc., GV (formerly Google Ventures), Roche Venture Fund, Kaiser Permanente Ventures, American Cancer Society’s BrightEdge Ventures, Data Collective Venture Capital, Novartis and Verily Life Sciences (formerly Google Life Sciences).
Our Science
Freenome is building technology to gain an understanding of the body
Pro unlocks apply links & auto-apply
Spam, scam, fake employer, broken apply link — let us know and we’ll review within 24h.
Report this listing